Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain

Journal of Neuroscience

Volumn 28, Issue 1, 2008, Pages 154-162

  Hédou, Gaël F ^a,b,d   Koshibu, Kyoko ^a,b   Farinelli, Mélissa ^a,b   Kilic, Ertugrul ^c   Gee, Christine E ^a,b,e   Kilic, Ulkan ^c   Baumgärtel, Karsten ^a,b   Hermann, Dirk M ^c   Mansuy, Isabelle M ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d GSK   (Italy)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cell death; Hippocampus; Ischemia; OGD; Plasticity; PP1

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN PHOSPHATASE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANOXIA; BRAIN ISCHEMIA; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DOXYCYCLINE; ELECTRIC STIMULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCOSE; HIPPOCAMPUS; LONG-TERM SYNAPTIC DEPRESSION; MICE; MICE, INBRED C57BL; NEURONAL PLASTICITY; PROTEIN PHOSPHATASE 1; PROTEINS; PYRANS; RECOVERY OF FUNCTION; SPIRO COMPOUNDS;

EID: 38149063810     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4109-07.2008     Document Type: Article

References (65)

1. Aarts MM, Tymianski M (2003) Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors. Biochem Pharmacol 66:877-886.
2. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci USA 96:12866-12869.
3. Aronowski J, Grotta JC, Strong R, Waxham MN (2000) Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. J Cereb Blood Flow Metab 20:343-349.
4. Arundine M, Tymianski M (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34:325-337.
5. Arundine M, Tymianski M (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61:657-668.
6. Asai A, Qiu J, Narita Y, Chi S, Saito N, Shinoura N, Hamada H, Kuchino Y, Kirino T (1999) High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem 274:34450-34458.
7. Ayllon V, Martinez AC, Garcia A, Cayla X, Rebollo A (2000) Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 19:2237-2246.
8. Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R, Landau EM (1998) Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science 280:1940-1942.
9. Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK (2004) Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 1697:89-101.
10. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C (2003) A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9:1180-1186.
11. Brichese L, Cazettes G, Valette A (2004) JNK is associated with Bcl-2 and PP1 in mitochondria: paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2. Cell Cycle 3:1312-1319.
12. Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G (2003) Synaptic plasticity in the ischaemic brain. Lancet Neurol 2:622-629.
13. Chu CT, Levinthal DJ, Kulich SM, Chalovich EM, DeFranco DB (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur J Biochem 271:2060-2066.
14. Colbran RJ (2004) Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity. J Neurosci 24:8404-8409.
15. Evans GL, Wang Y (2005) LTP induction prevents neurodegeneration in the CA1 region of the hippocampus in rats exposed to kainic acid in vivo. Soc Neurosci Abstr 31:967.6.
16. Farrokhnia N, Roos MW, Terent A, Lennmyr F (2005) Differential early mitogen-activated protein kinase activation in hyperglycemic ischemic brain injury in the rat. Eur J Clin Invest 35:457-463.
17. Fernandez MT, Zitko V, Gascon S, Torreblanca A, Novelli A (1993) Neurotoxic effect of okadaic acid, a seafood-related toxin, on cultured cerebellar neurons. Ann NY Acad Sci 679:260-269.
18. Fladmark KE, Brustugun OT, Hovland R, Boe R, Gjertsen BT, Zhivotovsky B, Doskeland SO (1999) Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ 6:1099-1108.
19. Fowler JC (1989) Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice. Brain Res 490:378-384.
20. Gao TM, Pulsinelli WA, Xu ZC (1998) Prolonged enhancement and depression of synaptic transmission in CA1 pyramidal neurons induced by transient forebrain ischemia in vivo. Neuroscience 87:371-383.
21. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418:970-975.
22. Guan QH, Pei DS, Xu TL, Zhang GY (2006) Brain ischemia/reperfusion- induced expression of DP5 and its interaction with Bcl-2, thus freeing Bax from Bcl-2/Bax dimmers are mediated by c-Jun N-terminal kinase (JNK) pathway. Neurosci Lett 393:226-230.
23. Gupta V, Ogawa AK, Du X, Houk KN, Armstrong RW (1997) A model for binding of structurally diverse natural product inhibitors of protein phosphatases PP1 and PP2A. J Med Chem 40:3199-3206.
24. Hermann DM, Kilic E, Kugler S, Isenmann S, Bahr M (2001) Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis 8:655-666.
25. Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050-2055.
26. Hori N, Carpenter DO (1994) Functional and morphological changes induced by transient in vivo ischemia. Exp Neurol 129:279-289.
27. Horiguchi T, Shima H, Suga S, Ogino M, Shimizu K, Toya S, Nagao M, Kawase T (2002) Transient forebrain ischemia induces expression of serine/threonine protein phosphatase 1 mRNA in the vulnerable regions of gerbil brain. Neurosci Lett 325:115-118.
28. Irving EA, Bamford M (2002) Role of mitogen- and stress-activated kinases in ischemic injury. J Cereb Blood Flow Metab 22:631-647.
29. Jouvenceau A, Hedou G, Potier B, Kollen M, Dutar P, Mansuy IM (2006) Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci 24:564-572.
30. Katsura KI, Kurihara J, Kato H, Katayama Y (2001) Ischemic preconditioning affects the subcellular distribution of protein kinase C and calcium/calmodulin-dependent protein kinase II in the gerbil hippocampal CA1 neurons. Neurol Res 23:751-754.
31. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM (2005) Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19:2026-2028.
32. Klumpp S, Krieglstein J (2002) Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2:458-462.
33. Legos JJ, Tuma RF, Barone FC (2002) Pharmacological interventions for stroke: failures and future. Expert Opin Investig Drugs 11:603-614.
34. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568.
35. Lisman JE, Zhabotinsky AM (2001) A model of synaptic memory: a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly. Neuron 31:191-201.
36. Lobner D, Lipton P (1993) Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia: relationship to electrophysiological cell damage. J Neurosci 13:4861-4871.
37. Lushnikova IV, Voronin KY, Malyarevskyy PY, Skibo GG (2004) Morphological and functional changes in rat hippocampal slice cultures after short-term oxygen-glucose deprivation. J Cell Mol Med 8:241-248.
38. Manfroid I, Martial JA, Muller M (2001) Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300. Mol Endocrinol 15:625-637.
39. Mansuy IM, Shenolikar S (2006) Protein serine/threonine phosphatases in neuronal plasticity and disorders of learning and memory. Trends Neurosci 29:679-686.
40. Mansuy IM, Mayford M, Jacob B, Kandel ER, Bach ME (1998) Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell 92:39-49.
41. Michalon A, Koshibu K, Baumgartel K, Spirig DH, Mansuy IM (2005) Inducible and neuron-specific gene expression in the adult mouse brain with the rtTA2S-M2 system. Genesis 43:205-212.
42. Morioka M, Hamada J, Ushio Y, Miyamoto E (1999) Potential role of calcineurin for brain ischemia and traumatic injury. Prog Neurobiol 58:1-30.
43. Morishita W, Connor JH, Xia H, Quinlan EM, Shenolikar S, Malenka RC (2001) Regulation of synaptic strength by protein phosphatase 1. Neuron 32:1133-1148.
44. Nuydens R, de Jong M, Van Den Kieboom G, Heers C, Dispersyn G, Cornelissen F, Nuyens R, Borgers M, Geerts H (1998) Okadaic acid-induced apoptosis in neuronal cells: evidence for an abortive mitotic attempt. J Neurochem 70:1124-1133.
45. Olney JW, Sharpe LG (1969) Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 166:386-388.
46. Onodera H, Yamasaki Y, Kogure K, Miyamoto E (1995) Calcium/calmodulin- dependent protein kinase II and protein phosphatase 2B (calcineurin) immunoreactivity in the rat hippocampus long after ischemia. Brain Res 684:95-98.
47. Papas S, Crepel V, Ben-Ari Y (1993) The NMDA receptor contributes to anoxic aglycemic induced irreversible inhibition of synaptic transmission. Brain Res 607:54-60.
48. Quevedo C, Salinas M, Alcazar A (2003) Initiation factor 2B activity is regulated by protein phosphatase 1, which is activated by the mitogen-activated protein kinase-dependent pathway in insulin-like growth factor 1-stimulated neuronal cells. J Biol Chem 278:16579-16586.
49. Quintana P, Alberi S, Hakkoum D, Muller D (2006) Glutamate receptor changes associated with transient anoxia/hypoglycaemia in hippocampal slice cultures. Eur J Neurosci 23:975-983.
50. Raley-Susman KM, Lipton P (1990) In vitro ischemia and protein synthesis in the rat hippocampal slice: the role of calcium and NMDA receptor activation. Brain Res 515:27-38.
51. Runden E, Seglen PO, Haug FM, Ottersen OP, Wieloch T, Shamloo M, Laake JH (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism. J Neurosci 18:7296-7305.
52. Sattler R, Tymianski M (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med 78:3-13.
53. Shackelford DA, Yeh RY (2006) Modulation of ERK and JNK activity by transient forebrain ischemia in rats. J Neurosci Res 83:476-488.
54. Sharkey J, Butcher SP (1994) Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371:336-339.
55. Sharkey J, Crawford JH, Butcher SP, Marston HM (1996) Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke 27:2282-2286.
56. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9:487-488.
57. Stevens TR, Krueger SR, Fitzsimonds RM, Picciotto MR (2003) Neuroprotection by nicotine in mouse primary cortical cultures involves activation of calcineurin and L-type calcium channel inactivation. J Neurosci 23:10093-10099.
58. Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, Narasimhan P, Maier CM, Chan PH (2004) Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1:17-25.
59. 2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284:339-343.
60. Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser ID, Langeberg LK, Sheng M, Scott JD (1999) Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285:93-96.
61. Winder DG, Sweatt JD (2001) Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2:461-474.
62. Yi KD, Chung J, Pang P, Simpkins JW (2005) Role of protein phosphatases in estrogen-mediated neuroprotection. J Neurosci 25:7191-7198.
63. Youssef FF, Addae JI, McRae A, Stone TW (2001) Long-term potentiation protects rat hippocampal slices from the effects of acute hypoxia. Brain Res 907:144-150.
64. Youssef FF, Addae JI, Stone TW (2003) LTP-induced depression of response to hypoxia in hippocampus: effects of adenosine receptor activation. NeuroReport 14:1809-1814.
65. Youssef FF, Addae JI, Stone TW (2006) NMDA-induced preconditioning attenuates synaptic plasticity in the rat hippocampus. Brain Res 1073-1074:183-189.